Understanding and Reducing Cardiovascular Disease in Type 1 Diabetes Mellitus (R01 Clinical Trial Optional)
Funding Opportunity RFA-HL-21-014 from the NIH Guide for Grants and Contracts. The goal of this funding opportunity is to support research that enhances the understanding of the pathophysiology and epidemiology of cardiovascular disease (CVD) among individuals with Type 1 Diabetes Mellitus (T1DM), and support the development of interventions to reduce CVD risk among these individuals. The overall goal is to develop evidence-based guidelines to prevent or reduce CVD complications of T1DM across the lifespan. This funding opportunity will support epidemiologic studies to refine risk assessment, mechanistic studies to enha...
Source: NIH Funding Opportunities (Notices, PA, RFA) - January 6, 2021 Category: Research Source Type: funding
Consortium Linking Oncology with Thrombosis (CLOT) (U01)
Funding Opportunity RFA-HL-18-021 from the NIH Guide for Grants and Contracts. The purpose of this FOA is to establish a program which will provide support for the collaborative efforts of oncologists and coagulation/vascular experts to identify, further develop, and implement advances in thrombosis and hemostasis research into practice for cancer patients. (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - July 12, 2017 Category: Research Source Type: funding
Notice of Intent to Publish a Funding Opportunity Announcement for the Consortium Linking Oncology with Thrombosis (CLOT) (U01)
Opportunity ID: 292254 Opportunity Number: NOT-HL-17-485 Opportunity Title: Notice of Intent to Publish a Funding Opportunity Announcement for the Consortium Linking Oncology with Thrombosis (CLOT) (U01)Opportunity Category: DiscretionaryOpportunity Category Explanation: Funding Instrument Type: Cooperative AgreementCategory of Funding Activity: HealthCategory Explanation: CFDA Number(s): 93.839Eligible Applicants: Additional Information on Eligibility: Agency Code: HHS-NIH11Agency Name: Department of Health and Human ServicesNational Institutes of HealthPosted Date: Mar 03, 2017Last Updated Date: ...
Source: Grants.gov - March 7, 2017 Category: Research Tags: Health Source Type: funding
Sex Hormone Induced Thromboembolism in Pre-Menopausal Women (R61/R33)
Funding Opportunity ID: 291259 Opportunity Number: RFA-HL-18-003 Opportunity Title: Sex Hormone Induced Thromboembolism in Pre-Menopausal Women (R61/R33)Opportunity Category: DiscretionaryOpportunity Category Explanation: Funding Instrument Type: GrantCategory of Funding Activity: HealthCategory Explanation: CFDA Number(s): 93.839Eligible Applicants: State governmentsCounty governmentsCity or township governmentsSpecial district governmentsIndependent school districtsPublic and State controlled institutions of higher educationNative American tribal governments (Federally recognized)Public housing authori...
Source: Grants.gov - February 19, 2017 Category: Research Tags: Health Source Type: funding
Notice of Intent to Publish a Funding Opportunity Announcement for the Consortium Linking Oncology with Thrombosis (CLOT) (U01)
Notice NOT-HL-17-485 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - February 1, 2017 Category: Research Source Type: funding
Sex Hormone Induced Thromboembolism in Pre-Menopausal Women (R61/R33)
Funding Opportunity ID: 291259 Opportunity Number: RFA-HL-18-003 Opportunity Title: Sex Hormone Induced Thromboembolism in Pre-Menopausal Women (R61/R33)Opportunity Category: DiscretionaryOpportunity Category Explanation: Funding Instrument Type: GrantCategory of Funding Activity: HealthCategory Explanation: CFDA Number(s): 93.839Eligible Applicants: State governmentsCounty governmentsCity or township governmentsSpecial district governmentsIndependent school districtsPublic and State controlled institutions of higher educationNative American tribal governments (Federally recognized)Public housing authori...
Source: Grants.gov - January 18, 2017 Category: Research Tags: Health Source Type: funding
Sex Hormone Induced Thromboembolism in Pre-Menopausal Women (R61/R33)
Funding Opportunity RFA-HL-18-003 from the NIH Guide for Grants and Contracts. The primary objective of the work to be supported by this funding opportunity is to understand the mechanisms by which female sex hormones and sex hormone-based therapies can increase the risk of venous and arterial thromboembolism in pre-menopausal women. Understanding the basic physiopathology of how sex hormones may induce or add to the pre-existing risk of thrombosis will strengthen our understanding of the mechanisms underlying thrombus formation in relevant clinical situations such as peripartum or in women using contraceptives or under...
Source: NIH Funding Opportunities (Notices, PA, RFA) - January 17, 2017 Category: Research Source Type: funding
Notice of Intent to Publish a Funding Opportunity Announcement for Sex Hormone Induced Thromboembolism in Pre-Menopausal Women (R61/R33)
Opportunity ID: 291105 Opportunity Number: NOT-HL-16-477 Opportunity Title: Notice of Intent to Publish a Funding Opportunity Announcement for Sex Hormone Induced Thromboembolism in Pre-Menopausal Women (R61/R33)Opportunity Category: DiscretionaryOpportunity Category Explanation: Funding Instrument Type: GrantCategory of Funding Activity: HealthCategory Explanation: CFDA Number(s): 93.839Eligible Applicants: Additional Information on Eligibility: Agency Code: HHS-NIH11Agency Name: Department of Health and Human ServicesNational Institutes of HealthPosted Date: Jan 06, 2017Last Updated Date: Jan 06,...
Source: Grants.gov - January 6, 2017 Category: Research Tags: Health Source Type: funding
Notice of Intent to Publish a Funding Opportunity Announcement for Sex Hormone Induced Thromboembolism in Pre-Menopausal Women (R61/R33)
Notice NOT-HL-16-477 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - December 5, 2016 Category: Research Source Type: funding
2015 Hemostasis and Thrombosis Research Society/Novo Nordisk Clinical Fellowship Awards in Hemophilia and Rare Bleeding Disorders
The Hemostasis and Thrombosis Research Society (“HTRS”) and Novo Nordisk Inc. (“Novo Nordisk”) announce the availability of two awards in 2015 for clinical fellowships focused on hemophilia and rare bleeding disorders for one academic year (July 1, 2015 - June 30, 2016). During the fellowship year, awardees are mentored by experienced MDs or DOs working in hemophilia or rare bleeding disorders at established U.S. hemostasis treatment centers (“HTCs”). Eligibility Applicants must be adult or pediatric hematology/oncology MDs or DOs who will have completed a fellowship in ...
Source: ScanGrants feed - October 28, 2014 Category: Research Authors: Hemostasis and Thrombosis Research Society/Novo Nordisk Source Type: funding
2015 Thrombosis and Hemostasis Societies of North America Mentored Research Award
The 2015 Thrombosis and Hemostasis Societies of North America (THSNA) Mentored Research Award (MRA) provides financial support for a clinical or basic science research project in hemostasis and/or thrombosis under the guidance of an experienced mentor. Eligible applicants and mentors may be from any of a variety of health related disciplines (i.e. physicians who are fellows or junior faculty, nurses, pharmacists, laboratory technologists, PhDs) represented within THSNA as outlined under the sections pertaining to eligibility requirements in the THSNA MRA Program Announcement. The 2015 THSNA MRA is funded by th...
Source: ScanGrants feed - October 28, 2014 Category: Research Authors: Thrombosis and Hemostasis Societies of North America Source Type: funding
Distinguished Scholar in Thrombosis Grant
GlaxoSmithKline Distinguished Scholar in Thrombosis $150,000 awarded over 3 years Application Deadline: extended to June 30 The Distinguished Scholar in Thrombosis grant supports clinical educational projects to improve patient care and is intended for the investigation of issues that are not easily supported through traditional funding. The grant will support a Fellow of the American College of Chest Physicians (FCCP) who is a recognized clinician and/or scientist with a specialty in thrombosis as evidenced by publications, presentations, and peers. The applicant must propose a thrombosis-related project ...
Source: ScanGrants feed - June 16, 2014 Category: Research Authors: American College of Chest Physicians Source Type: funding
Call for Nominations: American Diabetes Association Edwin Bierman Award
This lecture is awarded in honor of the memory of Edwin L. Bierman, MD. Dr. Bierman was an exemplary scientist, mentor and leader in the field of diabetes, obesity, hyperlipidemia and atherosclerosis. The award and lecture recognizes a leading scientist in the field of macrovascular complications and contributing risk factors in diabetes. Dr. Bierman is most notably remembered for his work on the physiologic and nutritional regulation of lipoprotein metabolism and the nature of lipid and lipoprotein disorders particularly in obesity and diabetes, and especially as these relate to atherosclerosis. He was also a pio...
Source: ScanGrants feed - May 21, 2014 Category: Research Authors: American Diabetes Association Source Type: funding
CHEST Foundation 2014 Grants and Awards Program
Each year, The CHEST Foundation offers CHEST members grants for clinical and translational research, leadership, and volunteer community service. Nearly 800 recipients worldwide have received more than $9 million to support and recognize outstanding work in chest medicine. Application deadline: May 31 For more information, contact: Dr. Sydney Parker, Director, Grants and Awards Phone: 224/521-9528 sparker@chestnet.org Distinguished Scholar in Thrombosis Grant GlaxoSmithKline Distinguished Scholar in Thrombosis $150,000 awarded over 3 years Application Deadline: May 31 The Distinguis...
Source: ScanGrants feed - March 17, 2014 Category: Research Authors: CHEST Foundation Source Type: funding
Public Health Surveillance of Deep Vein Thrombosis and Pulmonary Embolism CDC-RFA-DD11-1109
Funding Opportunity Number: CDC-RFA-DD14-1407 Opportunity Category: ContinuationFunding Instrument Type: Cooperative AgreementCategory of Funding Activity: HealthCFDA Number: 93.184Eligible Applicants Others (see text field entitled "Additional Information on Eligibility" for clarification)Agency Name: HHS-CDCClosing Date: Mar 14, 2014Award Ceiling: $400,000Expected Number of Awards: 2Creation Date: Feb 14, 2014Funding Opportunity Description: The purpose of the program is to develop and evaluate pilot programs for population based surveillance of deep vein thrombosis and pulmonary...
Source: Grants.gov - February 14, 2014 Category: Research Tags: Health Source Type: funding
